ArticleThe international journal of cardiovascular imaging2026
Regional left ventricular strain recovery after percutaneous mitral balloon valvuloplasty: determinants and prognostic implications.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In severe rheumatic mitral stenosis (MS), left ventricular (LV) systolic function is often considered preserved based on ejection fraction. However, longitudinal myocardial mechanics may be impaired and may improve after relief of inflow obstruction. The regional pattern of strain recovery following percutaneous mitral balloon valvuloplasty (PMBV), and its prognostic implications remain uncertain. To characterize global and regional LV strain response following PMBV, identify determinants of limited strain recovery, and evaluate its association with long-term outcomes. In 190 patients with severe symptomatic MS undergoing PMBV, LVGLS was measured by speckle-tracking echocardiography before and within 48 h after intervention. Absence of meaningful recovery was defined as ≤ 15% relative GLS improvement. The secondary endpoint was cardiovascular death or subsequent mitral valve replacement. PMBV significantly increased mitral valve area and reduced transmitral gradients, with concomitant improvement in GLS despite unchanged ejection fraction. Strain recovery demonstrated a distinct basal-to-apical gradient, with the greatest improvement in basal segments. In 29% of patients, absent GLS improvement was observed. Limited recovery was independently associated with larger baseline valve area, reduced leaflet displacement, lower pre-procedural left atrial pressure, and higher post-procedural pulmonary artery pressure. Over 48 months of follow-up, adverse outcomes were independently predicted by age, advanced NYHA class, smaller post-procedural valve area, higher residual gradient, and greater mitral regurgitation severity. Absence of GLS improvement was not associated with long-term events. In severe rheumatic MS, PMBV leads to an immediate improvement in LV longitudinal mechanics, characterized by a distinct basal predominance of recovery. This response appears largely load-mediated and does not independently translate into improved prognosis, which is primarily determined by procedural success and the degree of residual valve obstruction.
Indexed as
Identifiers
42754744What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.